Pathological Appearance of Focal Liver Reactions after Radiotherapy for Hepatocellular Carcinoma.

focal liver reaction hepatocellular carcinoma hypofractionated radiotherapy pathology stereotactic body radiotherapy

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
25 Apr 2022
Historique:
received: 07 04 2022
revised: 21 04 2022
accepted: 21 04 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 29 5 2022
Statut: epublish

Résumé

We studied five pathological specimens from five patients at 1.5, 3.0, 4.0, 13.5, and 14.0 months after radiotherapy for HCC. Four needle biopsies were obtained to investigate liver parenchyma of focal liver reaction (FLR) around treated HCC, when patients had newly developed HCC or local recurrence appeared in the liver. Liver resection was performed in one case where insufficient radiotherapy effect for HCC was suspected. In all patients, FLR was recognized as a hypervascular area around the HCC on enhanced CT and enhanced Gd-EOB-DTPA (EOB-MRI). Liver specimens were analyzed to assess the pathological characteristics of FLR. FLR was recognized as prolonged liver enhancement in enhanced CT and EOB-MRI. From pathological understanding, sinusoidal dilatation with degeneration and desquamation was caused by direct endothelial cell injury following radiotherapy. Hepatocytes and endothelium fell off, and so the portal tract came close, and hepatic arteries increase simultaneously, resulting in FLR around HCC after radiotherapy. In conclusion, the prolapse of hepatocytes and sinusoidal endothelium induced neovascularization of hepatic arteries due to the repair mechanisms; in addition, these prolapse may shorten the distance between each portal region and the hepatic arteries flowing through the portal region become more prominent in FLR.

Identifiants

pubmed: 35626228
pii: diagnostics12051072
doi: 10.3390/diagnostics12051072
pmc: PMC9139971
pii:
doi:

Types de publication

Case Reports

Langues

eng

Subventions

Organisme : Grant-in-Aid for Scientific Research on Innovative Areas (KAKENHI)
ID : 16K10289

Références

Br J Radiol. 2010 Dec;83(996):1063-71
pubmed: 21088090
Cancer. 2016 Jul 1;122(13):2041-9
pubmed: 27062278
Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):306-11
pubmed: 24411601
J Clin Oncol. 2015 Feb 20;33(6):550-8
pubmed: 25512453
Radiat Oncol. 2013 Oct 27;8:249
pubmed: 24160910
Oncol Lett. 2016 Jan;11(1):208-212
pubmed: 26870190
Hepatology. 2011 Mar;53(3):1020-2
pubmed: 21374666
Exp Mol Med. 2017 Jul 21;49(7):e359
pubmed: 28729640
Jpn J Radiol. 2015 Oct;33(10):627-35
pubmed: 26227061
J Gastroenterol Hepatol. 2014 Feb;29(2):372-9
pubmed: 23927053
Br J Radiol. 2018 May;91(1085):20170118
pubmed: 29334232
Semin Liver Dis. 2002 Feb;22(1):27-42
pubmed: 11928077
Jpn J Radiol. 2018 Apr;36(4):241-256
pubmed: 29508261
Liver Cancer. 2017 Nov;6(4):325-336
pubmed: 29234636
Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):444-51
pubmed: 12957256

Auteurs

Masahiro Okada (M)

Department of Radiology, Nihon University School of Medicine, Itabashi-ku, Tokyo 173-8610, Tokyo, Japan.
Gastroenterological Center, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Kanagawa, Japan.

Kazushi Numata (K)

Gastroenterological Center, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Kanagawa, Japan.

Hiromi Nihonmatsu (H)

Gastroenterological Center, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Kanagawa, Japan.

Kengo Tomita (K)

Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Defense Medical College, 3-2 Namiki, Tokorozawa-shi 359-8513, Saitama, Japan.

Atsuya Takeda (A)

Radiation Oncology Center, Ofuna Chuo Hospital, 6-2-24, Ofuna, Kamakura 247-0056, Kanagawa, Japan.

Kenichiro Tago (K)

Department of Radiology, Nihon University School of Medicine, Itabashi-ku, Tokyo 173-8610, Tokyo, Japan.

Tomoko Hyodo (T)

Department of Radiology, Kindai University Faculty of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama 589-8511, Osaka, Japan.

Takahisa Eriguchi (T)

Radiation Oncology Center, Ofuna Chuo Hospital, 6-2-24, Ofuna, Kamakura 247-0056, Kanagawa, Japan.

Masayuki Nakano (M)

Department of Pathology, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, Kanagawa, Japan.

Classifications MeSH